Compare IPHA & SGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IPHA | SGC |
|---|---|---|
| Founded | 1999 | 1920 |
| Country | France | United States |
| Employees | 163 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.5M | 181.8M |
| IPO Year | N/A | 1994 |
| Metric | IPHA | SGC |
|---|---|---|
| Price | $1.76 | $13.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $5.75 | ★ $16.00 |
| AVG Volume (30 Days) | 8.0K | ★ 53.4K |
| Earning Date | 03-26-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 4.93% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $566,184,000.00 |
| Revenue This Year | $180.36 | $3.23 |
| Revenue Next Year | N/A | $3.82 |
| P/E Ratio | ★ N/A | $220.50 |
| Revenue Growth | N/A | ★ 0.09 |
| 52 Week Low | $1.18 | $8.30 |
| 52 Week High | $2.63 | $14.59 |
| Indicator | IPHA | SGC |
|---|---|---|
| Relative Strength Index (RSI) | 49.08 | 55.85 |
| Support Level | $1.73 | $9.62 |
| Resistance Level | $1.80 | $14.59 |
| Average True Range (ATR) | 0.09 | 0.56 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 23.81 | 82.48 |
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.
Superior Group Of Companies Inc designs apparel products. The company operates through three segments: i) The Branded Products segment, under the brands BAMKO and HPI, produces and sells customized merchandising solutions, promotional products, and branded uniform programs. ii) The Healthcare Apparel segment, under the brands Wink and Fashion Seal Healthcare, manufactures and sells healthcare apparel including scrubs, lab coats, protective apparel, and patient garments. iii) The Contact Centers segment, through The Office Gurus entities, provides outsourced, nearshore, and onshore business process outsourcing (BPO), contact center, and call-center support services to customers in North America. The majority of the company's revenue is derived from the Branded Products segment.